Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: BIOXCEL THERAPEUTICS INC(BTAIQ) the Revenue is 182 K (+51.67%), Beat estimate;the EBIT is -10.19 M (+35.7%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.00B51.67%
0.00B41.05%
+0.00B10.62%
EBITExceed expectations
-0.01B35.70%
-0.01B29.66%
+0.00B6.04%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf